Literature DB >> 640723

Adherence of Bacteroides fragilis in vivo.

A B Onderdonk, N E Moon, D L Kasper, J G Bartlett.   

Abstract

The ability of the encapsulated species Bacteroides fragilis to adhere to rat peritoneal mesothelium was compared to the adherence of unecapsulated strains of Bacteroides (B. distasonis, B. vulgatus, B. thetaiotaomicron, B. ovatus, and B. "other"). Adherence was assayed by attaching plexiglas plates containing 8-mm holes to the peritoneal mesothelium of anesthetized rats. Cell suspension (0.25 ml) was incubated in each well, after which the suspension was aspirated, and a 4-mm punch biopsy was removed. Viable organisms adhering to the biopsy specimen were enumerated by plate count following washing of the biopsy tissue. It was found that B. fragilis adhered significantly better to mesothelial tissue (10(3.00) colony-forming units per biopsy) than unencapsulated species of Bacteroides (10(1.07) colony-forming units per biopsy). This effect was not due to differential oxygen sensitivity of the various inocula. Immunization of rats with capsular polysaccharide did not demonstrate decrease in the adherence of B. fragilis; however, preincubation of the mesothelium with purified capsular polysaccharide resulted in a substantial reduction in adherence. These results indicate that B. fragilis adheres to rat peritoneal mesothelium better than unencapsulated species and suggests that the capsular polysaccharide of B. fragilis plays some role in this increased adherence.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640723      PMCID: PMC422299          DOI: 10.1128/iai.19.3.1083-1087.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.

Authors:  A B Onderdonk; D L Kasper; R L Cisneros; J G Bartlett
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.

Authors:  D L Kasper
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

3.  Specificity of inhibition of epithelial cell adhesion of Neisseria gonorrhoeae.

Authors:  E C Tramont
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

4.  Isolation and identification of encapsulated strains of Bacteroides fragilis.

Authors:  D L Kasper; M E Hayes; B G Reinap; F O Craft; A B Onderdonk; B F Polk
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

5.  Bacteroides fragilis subspecies in clinical isolates.

Authors:  B F Polk; D L Kasper
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

6.  Parameters affecting the adherence and tissue tropisms of Streptococcus pyogenes.

Authors:  R P Ellen; R J Gibbons
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

7.  Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.

Authors:  D L Kasper; A B Onderdonk; J G Bartlett
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

8.  M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence.

Authors:  R P Ellen; R J Gibbons
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

9.  Experimental intra-abdominal abscesses in rats: development of an experimental model.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

10.  Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals.

Authors:  A B Onderdonk; W M Weinstein; N M Sullivan; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  19 in total

Review 1.  Serological responses to antigens of Bacteroidaceae.

Authors:  T Hofstad
Journal:  Microbiol Rev       Date:  1979-03

2.  Attachment of bacteria to mammalian surfaces.

Authors:  B Sugarman
Journal:  Infection       Date:  1980       Impact factor: 3.553

3.  Adherence of Bacteroides fragilis group species.

Authors:  I Brook; M L Myhal
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

4.  Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.

Authors:  C G Gemmell; P K Peterson; D Schmeling; J Mathews; P G Quie
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

5.  Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy.

Authors:  B Johne; J Jarp; L R Haaheim
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

6.  Attachment of Streptococcus faecium, to the duodenal epithelium of the chicken and its importance in colonization of the small intestine.

Authors:  R Fuller; S B Houghton; B E Brooker
Journal:  Appl Environ Microbiol       Date:  1981-06       Impact factor: 4.792

7.  Pathogenicity of piliated and encapsulated Bacteroides fragilis.

Authors:  I Brook; J C Coolbaugh; R I Walker
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

8.  Piliated Bacteroides fragilis strains adhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains.

Authors:  C Pruzzo; B Dainelli; M Ricchetti
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

9.  Growth of Bacteroides fragilis in rabbit tracheal organ culture: anaerobiosis and tissue respiration.

Authors:  T Murakami; T Matsuyama; S Shiraishi; B Hagihara
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

10.  Attachment of Actinomyces naeslundii to human buccal epithelial cells.

Authors:  J M Saunders; C H Miller
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.